TLR9 and diabetes mellitus: Toll-like receptor 9 (TLR9) deficiency and inhibitor decreases diabetes development by reducing proinflammatory cytokines and promoting anti-inflammatory cytokine release via enhancing CD73 expression in T cells in NOD mice.